ArticleExperimental lung research2011

Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses.

Alicia K Olivier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.